Sjogren’s Treatment Report – www.SjogrensTreatmentReport.com

This page tracks new and upcoming treatment options for Sjogren’s syndrome (SS). What’s in development? What’s promising? What’s available soon? Current topics include CP-25, CFZ533, VAY736, JAK inhibitors, RSLV-132, nuclease therapy, tofacitinib, LOU064, LO2A, anti-CD40 antibodies, AT-RvD1, fecal microbial transplant (FMT), RC-18, iguratimod, stem cells, BMP inhibitors, ustekinumab, AQP5, SS-1, and more.

Last updated: 3 years ago

News

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds Sep 30, 2020
Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests Sep 21, 2020
Ask the Expert: CBD Oil and Sjögren’s Aug 12, 2020
OMRF needs participants for Sjögren’s Syndrome study Aug 7, 2020
University of Queensland and CSL Limited partner up to progress treatments for Sjogren’s syndrome Jul 20, 2020
Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy for Sjogren’s Jul 15, 2020
Two Projects Using Hydrogel Biomaterials to Stimulate Tissue Regeneration Move Forward with New Funding Jul 14, 2020
Luminary Therapeutics and Case Western Reserve University enter formal collaboration for development of BAFF CAR-T (LMY-920) for Sjogren’s Syndrome Jul 7, 2020
Study identifies CP-25 as a potential drug for the treatment of primary Sjögren’s syndrome Jul 6, 2020
How the Hydroxychloroquine (HCQ) Shortage Highlights Sjogren’s Neglect Jun 16, 2020
The 2020 Sjögren’s Foundation National Patient Conference (June 26 & June 27, 2020) is going Virtual Jun 3, 2020
Wize Pharma Completes Phase IV Study of LO2A for the Treatment of Dry Eye Syndrome in Patients with Sjögren’s Syndrome May 7, 2020
Targeted Approach for Tackling Sjögren’s Syndrome – Small molecules restore salivary function in mice Apr 27, 2020
Abatacept Fails Clinical Trial for Sjögren’s Syndrome Mar 24, 2020
Phase 4 Trial of Treatment for Dry Eyes, LO2A Drops, in Sjögren’s Patients Fully Enrolled Jan 23, 2020
Wize Pharma Completes Patient Enrollment In Phase 4 Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren’s Syndrome Jan 21, 2020
Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers Jan 16, 2020
Hope for patients with rare Sjögren’s syndrome Oct 29, 2019
The Challenge of Identifying Sjogren’s Syndrome Sep 9, 2019
AT-RvD1 Restores Function of Salivary Glands, Decreases Harmful T-cells in Mouse Model of Sjögren’s Apr 2, 2019

News

Research

Clinical Trials

Projects

Discussion